Verve Therapeutics, Inc.

Q1 2023 13F Holders

Symbol: VERV
CUSIP: 92539P101
Type: Equity
Class: COM
Num filings: 133
Total reported value, excl. options: $912 M

Compare 2023 Q1 to

Manager	Report Date	Value ($000)	Shares	Option Type